We invest in technological innovations
Our investment focus is on innovative deep tech start-ups in the life sciences and industrial tech sectors in Germany, Switzerland and beyond.
Investing on the Edge of Science
The OCCIDENT Way of Investing
We are passionate about visionary founders who have the potential to change the future. As a venture capital investor, we are a financially strong, long-term and versatile partner. Our aim with each and every one of our investments is to make a positive contribution to society in a sustainable way.
Investment Criteria
Investment Areas
Have you developed an innovative technology that you want
to bring to the people?
to bring to the people?
Creating the Future Together
Take the step from scientific research to entrepreneurship: We are your partner for success
We specifically look for start-ups with technological innovations and visionary founders, who are seeking for investors for the first time.
Together with the founding team, we lay the foundation for the long-term financial viability of a start-up and ensure that founders remain motivated in the long term.
In this endeavor, we support our founders with professional know-how, experience, team spirit and enthusiasm for key issues in the future.
By acting intelligently, with foresight and in partnership at eye level, we succeed together in bringing the added value of a technology to the people and developing your start-up into a successful company.
As a holistic partner for financing and building a company, our experts from science and industry accompany you through this process with passion and commitment for a sustainable success.
We do it the OCCIDENT Way.
Take the crucial next step: OCCIDENT is your professional partner for many years to come
As a professional partner with many years of experience in building companies, OCCIDENT can support founders whose start-ups are in the development phase, have already received funding and are looking for further investors.
With professional know-how, an entrepreneurial mindset and enthusiasm, we make a vital contribution to the professionalization of your start-up.
We specifically look for visionary founding teams and start-ups with meaningful and sustainable deep tech innovations in order to accompany them on their journey to success.
To reach this goal, OCCIDENT proves time and again that we have staying power – our enthusiasm for revolutionary technologies is the driving force. We take your company that decisive step further.
We do it the OCCIDENT Way.
Want to learn more about OCCIDENT?
The OCCIDENT Way of Investing
Portfolio
Co-operation with the founding teams of our portfolio companies motivates and inspires us every day. We are energized by their passion and drive, and the often very intense exchange spurs us on to tackle challenges together.
Portfolio News
Tubulis Receives FDA Fast Track Designation
Tubulis’ TUB-040, an ADC for platinum-resistant ovarian cancer, receives FDA Fast Track, expediting its development in Phase I/IIa trials to address urgent cancer treatment needs.
Tubulis Doses First Patient in Phase I/IIa Trial for TUB-040
UB-040 targets an overexpressed antigen in ovarian and lung adenocarcinoma. The trial will enroll up to 140 patients across the US, UK, and Europe.
Avelo collaborates with global health leaders in project “BreathForDiagnosis”
The €3 million research project is funded by the European Commission under “Horizon Europe”, and co-funded by the Swiss State Secretariat for Education, Research and Innovation (SERI).
The Science Investor.
OCCIDENT@ACADEMIA
As an early-stage deep tech investor, most of our portfolio companies are spin-offs from universities or research institutions. To further expand our collaboration with leading universities and research institutions, we have launched our OCCIDENT@ACADEMIA program to actively support young academic start-ups on their entrepreneurial journey. Below is a sample of some of our partners.
